/

Empresas

XY

No verificado

XYRA

Sobre qué escribimos

BiologíaFarmacéuticaMedio Ambiente/EcologíaSanidadStart-up

3 Comunicados de prensa

Ver todos los comunicados de prensa

Press Release cover image

04/03/2026

Salud

Fitness

Medicina - Varios

Medio Ambiente/Ecología

Agricultura

XYRA Announces Issuance of US Patent to Reduce the Risk of Heart Failure or Strokes by Reducing the Number and Duration of Atrial Fibrillations

Fuente

Editor

1.00

0

24/04/2025

Farmacéutica

Sanidad

Economía

Start-up

Biología

XYRA Announces the Issuance of a Fifth New US Patent in a Series of Patents Which Protect the Use of Budiodarone in the Management of Atrial Fibrillation till after 2040

Fuente

Editor

1.00

0

Press Release cover image

16/10/2024

Farmacéutica

Sanidad

Biología

XYRA Announces FDA Label Guidance for Managing Atrial Fibrillation with Budiodarone and Wearable Monitoring Devices

Fuente

Editor

1.00

0

Seguidores

0

Compatibilidad

0